NO3046901T3 - - Google Patents

Info

Publication number
NO3046901T3
NO3046901T3 NO14845373A NO14845373A NO3046901T3 NO 3046901 T3 NO3046901 T3 NO 3046901T3 NO 14845373 A NO14845373 A NO 14845373A NO 14845373 A NO14845373 A NO 14845373A NO 3046901 T3 NO3046901 T3 NO 3046901T3
Authority
NO
Norway
Application number
NO14845373A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013903573A external-priority patent/AU2013903573A0/en
Application filed filed Critical
Publication of NO3046901T3 publication Critical patent/NO3046901T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09Geometrical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO14845373A 2013-09-17 2014-09-17 NO3046901T3 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2013903573A AU2013903573A0 (en) 2013-09-17 Compositions for the treatment of hypertension and/or fibrosis
PCT/AU2014/000923 WO2015039173A1 (fr) 2013-09-17 2014-09-17 Compositions pour le traitement de l'hypertension et/ou d'une fibrose

Publications (1)

Publication Number Publication Date
NO3046901T3 true NO3046901T3 (fr) 2018-03-17

Family

ID=52687998

Family Applications (1)

Application Number Title Priority Date Filing Date
NO14845373A NO3046901T3 (fr) 2013-09-17 2014-09-17

Country Status (22)

Country Link
US (1) US9458093B2 (fr)
EP (1) EP3046901B1 (fr)
JP (1) JP6122548B2 (fr)
KR (1) KR101736416B1 (fr)
CN (1) CN105683152B (fr)
AP (1) AP2016009079A0 (fr)
AU (1) AU2014324078B2 (fr)
BR (1) BR112016005601B1 (fr)
CA (1) CA2924356C (fr)
DK (1) DK3046901T3 (fr)
ES (1) ES2655455T3 (fr)
IL (1) IL244621A (fr)
MX (1) MX368865B (fr)
MY (1) MY172557A (fr)
NO (1) NO3046901T3 (fr)
NZ (1) NZ717927A (fr)
PH (1) PH12016500497B1 (fr)
PL (1) PL3046901T3 (fr)
RU (1) RU2635564C2 (fr)
SG (1) SG11201601642WA (fr)
UA (1) UA118111C2 (fr)
WO (1) WO2015039173A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3284981B2 (ja) 1998-11-02 2002-05-27 株式会社デンソー 車両用交流発電機およびそのステータの製造方法
US9956166B2 (en) 2013-09-18 2018-05-01 Sorrento Therapeutics, Inc. Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
WO2016145479A1 (fr) * 2015-03-18 2016-09-22 Vectus Biosystems Limited Compositions pour le traitement de la fibrose et d'états associés à la fibrose
CN107614484B (zh) 2015-03-18 2020-09-25 维克图斯生物系统有限公司 用于治疗肾脏和/或肝脏疾病的组合物
EP3353147B1 (fr) * 2015-09-22 2021-01-13 Vectus Biosystems Limited Synthèse de composés terphényle
KR102395342B1 (ko) * 2016-04-13 2022-05-10 보드 오브 리젠츠 오브 디 유니버시티 오브 네브라스카 레시니페라톡신을 사용한 투여 방법 및 심혈관 질환을 치료하는 방법
NZ750495A (en) * 2016-07-28 2022-07-01 Vectus Biosystems Ltd Compositions for the treatment of pulmonary fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2694288B1 (fr) * 1992-06-30 1994-09-09 Rhone Poulenc Agrochimie Phenylbenzamides fongicides et procédés pour les préparer.
DK1768689T3 (en) * 2004-06-11 2014-12-01 Vectus Biosystems Ltd Compositions and methods for treating cardiovascular disease
NZ569401A (en) * 2005-12-09 2012-03-30 Vectus Biosystems Ltd VIP fragments and methods of use
US20120088737A2 (en) * 2009-10-02 2012-04-12 Ajinomoto Co., Inc Novel acyl guanidine derivatives
ES2694375T3 (es) * 2013-09-17 2018-12-20 Vectus Biosystems Limited Composiciones para el tratamiento de la hipertensión y/o de la fibrosis

Also Published As

Publication number Publication date
UA118111C2 (uk) 2018-11-26
NZ717927A (en) 2018-12-21
CN105683152A (zh) 2016-06-15
CA2924356C (fr) 2018-04-03
US9458093B2 (en) 2016-10-04
AP2016009079A0 (en) 2016-03-31
AU2014324078A1 (en) 2016-04-07
EP3046901B1 (fr) 2017-10-18
MX368865B (es) 2019-08-02
IL244621A (en) 2017-04-30
CA2924356A1 (fr) 2015-03-26
ES2655455T3 (es) 2018-02-20
MY172557A (en) 2019-12-02
RU2635564C2 (ru) 2017-11-14
AU2014324078B2 (en) 2016-12-15
IL244621A0 (en) 2016-04-21
BR112016005601B1 (pt) 2021-02-02
PH12016500497B1 (en) 2017-12-13
PH12016500497A1 (en) 2016-06-13
SG11201601642WA (en) 2016-04-28
MX2016003371A (es) 2016-10-21
EP3046901A1 (fr) 2016-07-27
RU2016112257A (ru) 2017-10-20
BR112016005601A8 (pt) 2020-02-18
DK3046901T3 (en) 2018-01-02
KR101736416B1 (ko) 2017-05-16
CN105683152B (zh) 2017-03-22
EP3046901A4 (fr) 2017-04-12
PL3046901T3 (pl) 2018-03-30
WO2015039173A1 (fr) 2015-03-26
JP6122548B2 (ja) 2017-04-26
US20160221933A1 (en) 2016-08-04
JP2016532632A (ja) 2016-10-20
KR20160074471A (ko) 2016-06-28

Similar Documents

Publication Publication Date Title
AP2016009275A0 (fr)
BR112015007533A2 (fr)
BR102016010778A2 (fr)
BR112014017733A2 (fr)
BR112014018502A2 (fr)
BR112014017739A2 (fr)
BR112014019326A2 (fr)
BR112014018516A2 (fr)
BR112014018480A2 (fr)
BR112014017855A2 (fr)
BR112014020341A2 (fr)
BR112014017765A2 (fr)
BR112015019074A2 (fr)
BR112016008224A2 (fr)
BR112014018468A2 (fr)
BR112014017901A2 (fr)
BR112014018207A2 (fr)
BR112016014791A2 (fr)
BR112014017722A2 (fr)
BR112014017653A2 (fr)
BR112016013106A2 (fr)
BR112014018578A2 (fr)
BR112014018483A2 (fr)
BR112016014764A2 (fr)
BR112016009321A2 (fr)